Remimazolam
- PMID: 39443046
- DOI: 10.1016/j.aan.2024.07.010
Remimazolam
Abstract
Remimazolam is a new reversible γ-aminobutyric acid type A agonist benzodiazepine that displays a fast onset of action, short recovery time with a safe cardiopulmonary profile and favorable pharmacokinetics in comparison with other intravenous sedatives.
Keywords: Anesthesia; Benzodiazepine; Hypnotic; Pharmacokinetics; Pharmacology; Remimazolam; Sedative-amnestic.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure The authors have nothing to disclose.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources